FDA Is Expanding Transparency Efforts To Focus On Industry Questions
This article was originally published in The Pink Sheet Daily
Executive Summary
Sharfstein said the agency has split up its transparency efforts into three groups, adding one dedicated to explaining its inner workings to regulated industry.